发明名称 Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression
摘要 <p>The invention relates to a combination of syrosingopine and a mitochondrial inhibitor, e.g. metformin or oligomycin, and the use of the combination of syrosingopine and a mitochondrial inhibitor for the treatment of cancer and for achieving immunosuppression. The invention also relates to a fluorescence-based method for predicting syrosingopine sensitivity of a cancer cell.</p>
申请公布号 AU2012206649(A1) 申请公布日期 2013.07.04
申请号 AU20120206649 申请日期 2012.01.09
申请人 UNIVERSITAT BASEL 发明人 BENJAMIN, DON;COLOMBI, MARCO;HALL, MICHAEL;MORONI, CHRISTOPH
分类号 A61K31/155;A61K31/35;A61K31/4745;A61K31/625;A61K31/7072 主分类号 A61K31/155
代理机构 代理人
主权项
地址